CSPC Pharmaceutical Group バランスシートの健全性
財務の健全性 基準チェック /56
CSPC Pharmaceutical Groupの総株主資本はCN¥36.5B 、総負債はCN¥388.9Mで、負債比率は1.1%となります。総資産と総負債はそれぞれCN¥47.9BとCN¥11.4Bです。 CSPC Pharmaceutical Groupの EBIT はCN¥6.4Bで、利息カバレッジ比率-29.4です。現金および短期投資はCN¥10.8Bです。
主要情報
1.1%
負債資本比率
CN¥388.87m
負債
| インタレスト・カバレッジ・レシオ | -29.4x |
| 現金 | CN¥10.82b |
| エクイティ | CN¥36.47b |
| 負債合計 | CN¥11.42b |
| 総資産 | CN¥47.90b |
財務の健全性に関する最新情報
Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Oct 16
Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Jun 17Is CSPC Pharmaceutical Group (HKG:1093) A Risky Investment?
Sep 21Does CSPC Pharmaceutical Group (HKG:1093) Have A Healthy Balance Sheet?
Jun 20Recent updates
Is CSPC Pharmaceutical Group Limited (HKG:1093) Trading At A 48% Discount?
Nov 15Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Oct 16Earnings Not Telling The Story For CSPC Pharmaceutical Group Limited (HKG:1093) After Shares Rise 26%
Sep 30CSPC Pharmaceutical Group Limited (HKG:1093) Investors Are Less Pessimistic Than Expected
Aug 08Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Jun 17CSPC Pharmaceutical Group Limited Just Recorded A 20% Revenue Beat: Here's What Analysts Think
May 29CSPC Pharmaceutical Group (HKG:1093) Has Announced A Dividend Of CN¥0.14
May 21CSPC Pharmaceutical Group (HKG:1093) Will Pay A Dividend Of CN¥0.14
Apr 29There's Reason For Concern Over CSPC Pharmaceutical Group Limited's (HKG:1093) Price
Apr 22CSPC Pharmaceutical Group's (HKG:1093) Dividend Will Be CN¥0.14
Apr 01CSPC Pharmaceutical Group Limited (HKG:1093) Shares Could Be 49% Below Their Intrinsic Value Estimate
Jan 22Some Confidence Is Lacking In CSPC Pharmaceutical Group Limited's (HKG:1093) P/E
Jan 04Are Investors Undervaluing CSPC Pharmaceutical Group Limited (HKG:1093) By 36%?
Oct 22Is CSPC Pharmaceutical Group (HKG:1093) A Risky Investment?
Sep 21CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 62% Above Its Share Price
Jul 09Does CSPC Pharmaceutical Group (HKG:1093) Have A Healthy Balance Sheet?
Jun 20CSPC Pharmaceutical Group's (HKG:1093) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 01CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To CN¥0.11
Apr 04CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 92% Above Its Share Price
Mar 12財務状況分析
短期負債: 1093の 短期資産 ( CN¥26.5B ) が 短期負債 ( CN¥10.4B ) を超えています。
長期負債: 1093の短期資産 ( CN¥26.5B ) が 長期負債 ( CN¥988.7M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: 1093総負債よりも多くの現金を保有しています。
負債の削減: 1093の負債対資本比率は、過去 5 年間で0.3%から1.1%に増加しました。
債務返済能力: 1093の負債は 営業キャッシュフロー によって 十分にカバー されています ( 1101.6% )。
インタレストカバレッジ: 1093支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。